Francisco J. Espinar-Otero
Santiago De Compostela, GA 15706, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 07, 2026
Impact of high cyclodextrins concentrations on ocular safety and surface permanence.
Journal: Drug delivery and translational research
Published: April 23, 2026
Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 26, 2026
Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model.
Journal: International journal of pharmaceutics: X
Published: March 03, 2026
Oral nanoparticle-encapsulated enzyme replacement therapy for mucopolysaccharidosis type I (MPS-I): a proof of concept study.
Journal: Drug delivery and translational research
Published: February 06, 2026
Evaluation of the exposure-response relationship of pembrolizumab in non-small cell lung cancer: observational study protocol in real-world clinical practice.
Journal: BMC cancer
Published: January 29, 2026
Optimization of nail therapies: the role of microstructure in the absorption and efficacy of topical treatments.
Journal: International journal of pharmaceutics
Published: December 17, 2025
Nail tattooing: a novel and minimally invasive technique for enhancing drug penetration through the nail.
Journal: Drug delivery and translational research
Published: December 12, 2025
Tolcapone-loaded nanostructured lipid carriers for improved oral delivery.
Journal: International journal of pharmaceutics
Published: November 25, 2025
Multifunctional hybrid chitosan/κ-carrageenan sponges integrating engineered SBA-15@Fe3O4 composites and nano-hydroxyapatite for bone tissue engineering.
Journal: International journal of biological macromolecules
Published: November 20, 2025
Long-term clinical outcomes of 0.015 % tacrolimus HPβCD eye drops in ocular surface inflammatory disorders.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 05, 2025
Design and evaluation of semi-solid lipid implants for controlled intravitreal release of bevacizumab.
Journal: International journal of pharmaceutics
Published: July 17, 2025
Last Updated: 09/26/2026